Similar articles

• The effects of liver disease and aging on the disposition of diazepam, chlordiazepoxide, oxazepam and lorazepam in man.

  Wilkinson GR. Wilkinson GR. Acta Psychiatr Scand Suppl. 1978;(274):56-74. doi: 10.1111/j.1600-0447.1978.tb02388.x. Acta Psychiatr Scand Suppl. 1978. PMID: 32740 No abstract available.
• Disposition and elimination of minor tranquilizers in the aged and in patients with liver disease.

  Hoyumpa AM Jr. Hoyumpa AM Jr. South Med J. 1978 Aug;71 Suppl 2:23-8. doi: 10.1097/00007611-197808001-00006. South Med J. 1978. PMID: 28572 No abstract available.
• Effects of aging and liver disease on disposition of lorazepam.

  Kraus JW, Desmond PV, Marshall JP, Johnson RF, Schenker S, Wilkinson GR. Kraus JW, et al. Clin Pharmacol Ther. 1978 Oct;24(4):411-9. doi: 10.1002/cpt1978244411. Clin Pharmacol Ther. 1978. PMID: 28871 No abstract available.
• Clinical pharmacokinetics of oxazepam and lorazepam.

  Greenblatt DJ. Greenblatt DJ. Clin Pharmacokinet. 1981 Mar-Apr;6(2):89-105. doi: 10.2165/00003088-198106020-00001. Clin Pharmacokinet. 1981. PMID: 6111408 Review.
• The effect of parenchymal liver disease on the disposition and elimination of sedatives and analgesics.

  Schenker S, Hoyumpa AM Jr, Wilkinson GR. Schenker S, et al. Med Clin North Am. 1975 Jul;59(4):887-96. doi: 10.1016/s0025-7125(16)31987-3. Med Clin North Am. 1975. PMID: 238085 Review. No abstract available.